NCT06781294 - SIRAKI 02 Posthoc Analysis. | Biotech Hunter

Enrollment

343

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions

Cardiac Surgery Requiring Cardiopulmonary BypassAcute Kidney InjuryChronic Kidney Disease(CKD)Kidney Failure, Acute

Interventions

DEVICE

Extracorporeal Cytokine hemadsorption therapy

Extracorporeal blood purification with oXiris set connected to cardiopulmonary bypass during all CPB time. Ultrafiltration was permitted.

Trial Locations (1)

Universitat de Barcelona, L'Hospitalet de Llobregat

All Listed Sponsors

collaborator

University of Barcelona

OTHER

collaborator

FundaciÃ³ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

UNKNOWN

collaborator

Hospital Germans TrÃ-es i Pujol de Badalona

UNKNOWN

lead

Hospital Universitari de Bellvitge

OTHER